title: Screening coagulation tests are underutilised in patients on dabigatran presenting with thromboembolic or haemorrhagic events.
authors.affiliation: Department of Medicine, University of Otago, Christchurch, New Zealand.
authors.forename: P K L
authors.initials: PK
authors.lastname: Chin
authors.affiliation: 2Department of General Medicine, Christchurch Hospital, Canterbury District Health Board, Canterbury, New Zealand.
authors.forename: A
authors.initials: A
authors.lastname: Fox
authors.affiliation: 2Department of General Medicine, Christchurch Hospital, Canterbury District Health Board, Canterbury, New Zealand.
authors.forename: M
authors.initials: M
authors.lastname: Marais
authors.affiliation: 2Department of General Medicine, Christchurch Hospital, Canterbury District Health Board, Canterbury, New Zealand.
authors.forename: J
authors.initials: J
authors.lastname: Tiong
mesh_terms: D000368:Aged; D000991:Antithrombins / Q000009:adverse effects*; D001780:Blood Coagulation Tests / Q000706:statistics & numerical data; D000069604:Dabigatran / Q000009:adverse effects*; D005260:Female; D006470:Hemorrhage / Q000097:blood* / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D008297:Male; D008875:Middle Aged; D013923:Thromboembolism / Q000097:blood* / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D000991:Antithrombins; D000069604:Dabigatran